Terminological Rigor in Nanomedicine: Standardizing 'Nano' Descriptors for Reproducibility and Translational Success
DOI:
https://doi.org/10.70099/BJ/2025.02.02.1Keywords:
nanomedicine, terminology standardization, drug delivery systems, scientific rigor, nanocarriers, size characterization, stimuli-responsive systems, targeted delivery, regulatory reproducibility, translational nanotechnology, EPR effect, nanoparticle characterization, academic integrityAbstract
The rapid growth of nanomedicine has revolutionized drug delivery innovations. Nevertheless, the scientific credibility is jeopardized by the uncritical use of "nano" terminology, which is frequently lacking in robust physicochemical or functional validation. This editorial denounces the misuse of terms such as "targeted delivery," "smart carriers," and "nanoparticles," which are frequently employed without experimental justification. We recommend concrete measures to standardize terminology, encouraging authors, journal editors, and educators to implement evidence-based definitions. To guarantee reproducibility, regulatory transparency, and successful clinical translation in nanomedicine, it is imperative to achieve rigorous semantic precision.
References
Park K. Facing the Truth about Nanotechnology in Drug Delivery. ACS Nano. 2013;7:7442–7447. doi:10.1021/NN404501G
Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014. doi:10.1038/natrevmats.2016.14
Öztürk K, Kaplan M, Çalış S. Effects of Nanoparticle Size, Shape, and Zeta Potential on Drug Delivery. Int J Pharm. 2024;666:124799. doi:10.1016/J.IJPHARM.2024.124799
Xia S, Duan Y, Yu S, et al. A Cellulosic Multi-Bands Fluorescence Probe for Rapid Detection of PH and Glutathione. Carbohydr Polym. 2024;331:121893. doi:10.1016/J.CARBPOL.2024.121893
Ramos TI, Villacis-Aguirre CA, Sandoval FS, Martin-Solano S, Manrique-Suárez V, Rodríguez H, Santiago-Padilla L, Debut A, Gómez-Gaete C, Arias MT, et al. Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment. Pharmaceutics. 2024; 16(11):1349. https://doi.org/10.3390/pharmaceutics16111349
Talele P, Jadhav A, Sahu S, Shimpi N. Experimental Approaches to Evaluate Solid Lipid Nanoparticle-Based Drug Delivery Systems. Anal Methods. 2025;17:1451–1466. doi:10.1039/D4AY01659A
Shreyash N, Sonker M, Bajpai S, Tiwary SK. Review of the Mechanism of Nanocarriers and Technological Developments in the Field of Nanoparticles for Applications in Cancer Theragnostics. ACS Appl Bio Mater. 2021;4:2307–2334. doi:10.1021/ACSABM.1C00020
Ruiz, A.; Suárez, M.; Mar
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with BioNatura Journal agree to the following terms: Authors retain copyright and grant the BioNatura Institutional Publishing Consortium (BIPC) right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.